Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006554 220002525 0 35.3 Curative (C) 2015-11-12 2015-11-18 AML Downs N N 220030539 NOT MATCHED
220006555 220002525 1.75 116.6 Curative (C) 2015-07-31 2015-08-01 AML 19 TRIAL 01 N 220030539 AML19 TRIAL
220006556 220002525 1.68 72.3 Curative (C) null 2016-12-27 AML 19 TRIAL Y N 220030539 AML19 TRIAL
220006557 220002526 null null Palliative (P) 2017-01-09 2017-01-10 Nilotinib N N 220030543 NILOTINIB
220006558 220002527 1.6 85.4 Palliative (P) 2014-01-07 2014-01-08 FLAG + Idarubicin N N 220030548 FLAG + IDARUBICIN
220006559 220002527 null null Curative (C) 2015-05-08 2015-05-30 Nilotinib N N 220030548 NILOTINIB
220006560 220002528 1.58 null Curative (C) 2015-02-03 2015-02-04 FLAG + Idarubicin N N 220030551 FLAG + IDARUBICIN
220006561 220002528 1.73 116.6 Curative (C) 2013-02-27 2013-02-27 AML 19 TRIAL 01 N 220030551 AML19 TRIAL
220006562 220002529 1.75 58.5 Curative (C) 2017-03-24 2017-03-24 FLAG + Idarubicin N N 220030553 FLAG + IDARUBICIN
220006563 220002529 0 null Curative (C) 2014-12-17 2014-12-17 Nilotinib 2 N 220030553 NILOTINIB
220006564 220002529 1.49 120 Disease modification (D) 2015-08-29 2015-08-29 Nilotinib N N 220030553 NILOTINIB
220006565 220002529 1.66 52.2 Curative (C) 2014-08-19 2014-08-20 AML 19 TRIAL Y N 220030553 AML19 TRIAL
220006566 220002529 1.85 95.8 Curative (C) 2017-03-24 2017-03-26 AML 19 TRIAL Y null 220030553 AML19 TRIAL
220006567 220002529 0 null Curative (C) 2013-09-16 2013-09-17 Nilotinib N N 220030553 NILOTINIB
220006568 220002529 1.51 null Disease modification (D) null 2017-06-05 ALL Ph+ve Dasatinib - Das alone N N 220030553 NOT MATCHED
220006569 220002530 null 72.5 Curative (C) 2014-11-18 2015-07-16 Nilotinib 2 N 220030568 NILOTINIB
220006570 220002531 0 70 Curative (C) 2014-12-31 2014-12-31 AML Interim Guidelines N N 220030570 NOT MATCHED
220006571 220002531 1.77 76.8 Curative (C) 2014-11-27 2014-12-03 AML 19 TRIAL 01 N 220030570 AML19 TRIAL
220006572 220016161 1.68 86.7 null 2015-12-08 2015-12-09 FLAG + Idarubicin N N 220030573 FLAG + IDARUBICIN
220006573 220016161 1.62 0 Curative (C) 2013-08-20 2013-08-20 null N N 220030573 NOT MATCHED
220006574 220016161 1.66 73.5 Curative (C) 2014-01-03 2014-01-05 AML 19 TRIAL N N 220030573 AML19 TRIAL
220006575 220016161 1.75 72 Curative (C) 2013-09-21 2013-09-21 AML 19 TRIAL 01 N 220030573 AML19 TRIAL
220006576 220002532 1.66 87.2 Curative (C) 2015-08-06 2015-08-06 AML 19 TRIAL 01 N 220030586 AML19 TRIAL
220006577 220002532 1.62 82 Curative (C) 2013-07-22 2013-07-22 AML 19 TRIAL 01 N 220030586 AML19 TRIAL
220006578 220002532 1.66 60.3 Curative (C) 2017-05-12 2017-05-12 AML 19 TRIAL Y N 220030586 AML19 TRIAL
220006579 220002532 1.61 null Curative (C) null 2014-01-22 FLAG + Idarubicin 2 N 220030586 FLAG + IDARUBICIN
220006580 220002532 0 38.1 Curative (C) 2014-12-18 2014-12-18 null 02 N 220030586 NOT MATCHED
220006581 220021255 0 78.3 Adjuvant (A) 2013-03-03 2013-03-04 Nilotinib N N 220030593 NILOTINIB
220006582 220002533 0 0 Disease modification (D) 2013-10-08 2013-10-08 Nilotinib 02 N 220030594 NILOTINIB
220006583 220002534 0 null Disease modification (D) 2014-02-18 2015-07-04 Nilotinib N N 220030597 NILOTINIB
220006584 220011458 1.6 0 Curative (C) 2016-04-16 2016-04-20 Nilotinib N N 220030600 NILOTINIB
220006585 220011458 null null Curative (C) null 2015-10-28 AML Interim Guidelines FLA null null 220030600 NOT MATCHED
220006586 220011458 1.74 0 Curative (C) 2015-10-21 2015-10-21 Nilotinib null null 220030600 NILOTINIB
220006587 220002535 1.72 null Curative (C) 2015-07-24 2015-07-24 Nilotinib 2 null 220030610 NILOTINIB
220006588 220002535 0 null Curative (C) 2013-07-19 2013-07-19 Nilotinib 2 N 220030610 NILOTINIB
220006589 220002535 0 0 Palliative (P) null 2014-10-17 Nilotinib 02 N 220030610 NILOTINIB
220006592 220002537 1.81 93.2 Disease modification (D) 2015-03-27 2015-11-23 Nilotinib 2 N 220030622 NILOTINIB
220006593 220002537 1.66 79.2 Curative (C) 2016-01-13 2016-01-13 AML 19 TRIAL 01 N 220030622 AML19 TRIAL
220006594 220002537 null 8.4 Curative (C) 2016-12-16 2016-12-17 AML Interim Guidelines FLA -Ida N N 220030622 NOT MATCHED
220006595 220002537 1.56 60.2 Curative (C) 2014-09-08 2014-09-08 AML 19 TRIAL Y null 220030622 AML19 TRIAL
220006596 220002538 1.68 81.4 Curative (C) 2014-10-31 2014-10-31 AML 19 TRIAL Y N 220030628 AML19 TRIAL
220006597 220002538 0 null Disease modification (D) 2016-09-28 2016-12-24 Nilotinib N null 220030628 NILOTINIB
220006598 220002539 1.74 53.8 Curative (C) 2014-08-06 2014-08-06 AML 19 TRIAL 01 null 220030630 AML19 TRIAL
220006599 220002539 1.72 94.1 Curative (C) 2014-08-06 2014-08-06 FLAG + Idarubicin null N 220030630 FLAG + IDARUBICIN
220006600 220002540 1.96 null null 2017-10-20 2017-10-27 FLAG + Idarubicin null null 220030636 FLAG + IDARUBICIN
220006601 220002541 1.15 73 Curative (C) 2016-07-12 2016-10-15 AML Interim Guidelines FLA 2 N 220030638 NOT MATCHED
220006604 220016166 1.77 86.1 Curative (C) 2014-09-30 2014-10-05 AML 19 TRIAL Y N 220030641 AML19 TRIAL
220006605 220016166 null null Disease modification (D) 2013-01-28 2013-09-28 Nilotinib null N 220030641 NILOTINIB
220006606 220016166 0 0 Disease modification (D) null 2016-03-26 Nilotinib 02 N 220030641 NILOTINIB
220006607 220021256 1.81 73 Curative (C) 2013-10-18 2013-10-18 Nilotinib 2 Y 220030648 NILOTINIB